Directory

>

Sherri Van Everen

avatar

Sherri Van Everen

Vice President, Ophthalmology Clinical Development | REGENXBIO

San Francisco, California, United States

View contact details (it's free)

Sherri Van Everen

Summary

Sherri Van Everen is an accomplished executive in the biotechnology sector, currently serving as Vice President of Ophthalmology Clinical Development at REGENXBIO Inc. With over two decades of experience, she has held various leadership roles in clinical development, medical affairs, and outcomes research. Sherri's educational background includes a Doctor of Pharmacy from The University of Texas at Austin and a Bachelor's in Biomedical Science from Texas A&M University. Her career spans notable organizations such as Genentech and Eli Lilly, where she has significantly contributed to drug development and clinical research initiatives. In addition to her corporate roles, Sherri is also a member of the Board of Directors at the Jack McGovern Coats Disease Foundation, showcasing her commitment to advancing healthcare beyond her professional obligations. Her expertise encompasses a wide range of areas, including immunology and oncology, making her a well-rounded leader in her field.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Non-Profit Experience

Sherri Van Everen

Work Experience

company logo

Vice President, Ophthalmology Clinical Development at

REGENXBIO

November 2018 - Present

company logo

Vice President Medical Affairs at

REGENXBIO

July 2016 - Present

💼

Member Board of Directors at

Jack Mcgovern Coats Disease Foundation

January 2016 - Present

company logo

Executive Director, Scientific Collaborations at

Adverum Biotechnologies

October 2014 - December 2015

company logo

Principal Medical Science Liaison at

Genentech Foundation

March 2012 - October 2014

company logo

Senior Medical Science Liaison at

Genentech Foundation

January 2006 - February 2012

company logo

Health Economist at

Genentech Foundation

January 2005 - January 2006

company logo

Outcomes Research Liaison at

Eli Lilly and Company

January 2001 - January 2005

company logo

Assistant Professor- School of Pharmacy at

Northeastern University Holdings LLC

January 1999 - January 2000

Sherri Van Everen

Education

The University of Texas at Austin, Doctor Of Pharmacy (Pharmd)

January 1995 - January 1999

Texas A&M University, Bs

January 1990 - January 1994

Frequently Asked Questions about Sherri Van Everen

What is Sherri Van Everen email address?

Sherri Van Everen's primary email address is **********@regenxbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Sherri Van Everen work for?

Sherri Van Everen is a Vice President, Ophthalmology Clinical Development at REGENXBIO, a company specializing in Commercial physical research.

Where Sherri Van Everen graduated from?

Sherri Van Everen holds a degree in Pharmacy from The University of Texas at Austin.

How can I directly contact Sherri Van Everen?

To contact Sherri Van Everen directly, you can use the email address **********@regenxbio.com. Complete contact information is available upon registration with Muraena.

Who is Sherri Van Everen?

Sherri Van Everen is an accomplished executive in the biotechnology sector, currently serving as Vice President of Ophthalmology Clinical Development at REGENXBIO Inc. With over two decades of experience, she has held various leadership roles in clinical development, medical affairs, and outcomes research. Sherri's educational background includes a Doctor of Pharmacy from The University of Texas at Austin and a Bachelor's in Biomedical Science from Texas A&M University. Her career spans notable organizations such as Genentech and Eli Lilly, where she has significantly contributed to drug development and clinical research initiatives. In addition to her corporate roles, Sherri is also a member of the Board of Directors at the Jack McGovern Coats Disease Foundation, showcasing her commitment to advancing healthcare beyond her professional obligations. Her expertise encompasses a wide range of areas, including immunology and oncology, making her a well-rounded leader in her field.

Sherri`s contact details

mail

**********@regenxbio.com

****************@gene.com

Colleagues

avatar
Paulo Falabella Md

Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases

avatar
Steve Pakola Md

Chief Medical Officer

avatar
Sumie Takahara

Executive Director, Global Product and Market Planning

avatar
Kim Pack

Executive Director Drug Delivery & Training

avatar
Sarah Thomas

Sr Vice President, Quality

avatar
Niall Carolan

Senior Vice President, Global Program Management & Alliance Management

avatar
Stacey Curtiss

Vice President, Medical Affairs

avatar
Shiva Fritsch

Chief Communications & People Officer

avatar
Dabt Justine Cunningham

VP, Nonclinical Development

avatar
Kirsten Cowley

Executive Director Clinical Operations

View Contact details (it's free)
Request Profile Removal